Global high throughput screening market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for high throughput screening in various applications such as hospitals and clinics, pharmaceutical companies, government organizations, and research facilities. High throughput screening helps in identifying potential drug candidates with desired properties such as efficacy and safety. It also helps in reducing the time taken for drug discovery process by eliminating drugs that are not likely to be effective or safe enough for human use.
The global high throughput screening market is segmented on the basis of type into software, instruments, consumables; on the basis of application into hospitals and clinics, pharmaceutical companies, government organizations and research facilities; on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
Some Of The Growth Factors Of This Market:
- The high throughput screening market is driven by the need for faster and more accurate drug discovery and development.
- High throughput screening market growth is also driven by the increasing number of clinical trials, which in turn increases demand for high-throughput screening services.
- Increasing government funding for research and development activities will drive the growth of the high throughput screening market.
- Increasing investments in R&D activities will fuel the growth of this market.
Industry Growth Insights published a new data on “High Throughput Screening Market”. The research report is titled “High Throughput Screening Market research by Types (Software, Instruments, Consumables, Others), By Applications (Hospitals and Clinics, Pharmaceutical Companies, Government Organizations, Research Facilities), By Players/Companies Aurora Biomed, Beckman Coulter, Agilent Technologies, Life Technologies Corporation, Luminex Corporation, Roche, Sigma-Aldrich, Bio-Rad Laboratories, Thermo Fisher Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
High Throughput Screening Market Research Report
By Type
Software, Instruments, Consumables, Others
By Application
Hospitals and Clinics, Pharmaceutical Companies, Government Organizations, Research Facilities
By Companies
Aurora Biomed, Beckman Coulter, Agilent Technologies, Life Technologies Corporation, Luminex Corporation, Roche, Sigma-Aldrich, Bio-Rad Laboratories, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global High Throughput Screening Market Report Segments:
The global High Throughput Screening market is segmented on the basis of:
Types
Software, Instruments, Consumables, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Pharmaceutical Companies, Government Organizations, Research Facilities
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aurora Biomed
- Beckman Coulter
- Agilent Technologies
- Life Technologies Corporation
- Luminex Corporation
- Roche
- Sigma-Aldrich
- Bio-Rad Laboratories
- Thermo Fisher Scientific
Highlights of The High Throughput Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Software
- Instruments
- Consumables
- Others
- By Application:
- Hospitals and Clinics
- Pharmaceutical Companies
- Government Organizations
- Research Facilities
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High Throughput Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
High throughput screening (HTS) is a method for rapidly and efficiently identifying small molecules that have the potential to be novel drugs or inhibitors of disease. HTS uses high-throughput screening methods such as mass spectrometry, chromatography, and nuclear magnetic resonance spectroscopy to identify candidate molecules from large libraries of compounds.
Some of the major companies in the high throughput screening market are Aurora Biomed, Beckman Coulter, Agilent Technologies, Life Technologies Corporation, Luminex Corporation, Roche, Sigma-Aldrich, Bio-Rad Laboratories, Thermo Fisher Scientific.
The high throughput screening market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. High Throughput Screening Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. High Throughput Screening Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. High Throughput Screening Market - Supply Chain
4.5. Global High Throughput Screening Market Forecast
4.5.1. High Throughput Screening Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. High Throughput Screening Market Size (000 Units) and Y-o-Y Growth
4.5.3. High Throughput Screening Market Absolute $ Opportunity
5. Global High Throughput Screening Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. High Throughput Screening Market Size and Volume Forecast by Type
5.3.1. Software
5.3.2. Instruments
5.3.3. Consumables
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global High Throughput Screening Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. High Throughput Screening Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Pharmaceutical Companies
6.3.3. Government Organizations
6.3.4. Research Facilities
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global High Throughput Screening Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. High Throughput Screening Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global High Throughput Screening Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. High Throughput Screening Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global High Throughput Screening Demand Share Forecast, 2019-2026
9. North America High Throughput Screening Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America High Throughput Screening Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America High Throughput Screening Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Pharmaceutical Companies
9.4.3. Government Organizations
9.4.4. Research Facilities
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America High Throughput Screening Market Size and Volume Forecast by Type
9.7.1. Software
9.7.2. Instruments
9.7.3. Consumables
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America High Throughput Screening Demand Share Forecast, 2019-2026
10. Latin America High Throughput Screening Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America High Throughput Screening Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America High Throughput Screening Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Pharmaceutical Companies
10.4.3. Government Organizations
10.4.4. Research Facilities
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America High Throughput Screening Market Size and Volume Forecast by Type
10.7.1. Software
10.7.2. Instruments
10.7.3. Consumables
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America High Throughput Screening Demand Share Forecast, 2019-2026
11. Europe High Throughput Screening Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe High Throughput Screening Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe High Throughput Screening Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Pharmaceutical Companies
11.4.3. Government Organizations
11.4.4. Research Facilities
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe High Throughput Screening Market Size and Volume Forecast by Type
11.7.1. Software
11.7.2. Instruments
11.7.3. Consumables
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe High Throughput Screening Demand Share, 2019-2026
12. Asia Pacific High Throughput Screening Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific High Throughput Screening Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific High Throughput Screening Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Pharmaceutical Companies
12.4.3. Government Organizations
12.4.4. Research Facilities
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific High Throughput Screening Market Size and Volume Forecast by Type
12.7.1. Software
12.7.2. Instruments
12.7.3. Consumables
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific High Throughput Screening Demand Share, 2019-2026
13. Middle East & Africa High Throughput Screening Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa High Throughput Screening Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa High Throughput Screening Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Pharmaceutical Companies
13.4.3. Government Organizations
13.4.4. Research Facilities
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa High Throughput Screening Market Size and Volume Forecast by Type
13.7.1. Software
13.7.2. Instruments
13.7.3. Consumables
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa High Throughput Screening Demand Share, 2019-2026
14. Competition Landscape
14.1. Global High Throughput Screening Market: Market Share Analysis
14.2. High Throughput Screening Distributors and Customers
14.3. High Throughput Screening Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Aurora Biomed
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Beckman Coulter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Life Technologies Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Luminex Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roche
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sigma-Aldrich
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio-Rad Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
